As a longtime researcher of respiratory syncytial virus (RSV), Eric Simões, MD, was gratified in August when clinical trials he led at the University of Colorado School of Medicine received the U.S. Food and Drug Administration’s approval for Pfizer’s new RSV vaccine for use during late pregnancy.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045